Compare Cardinal Health Inc (CAH) vs Global E Online Ltd (GLBE) Price & Performance

Cardinal Health (CAH) trades at $236.87, down 0.13% on the day, near its 52-week high. The stock shows strong momentum with four consecutive quarterly EPS beats, including Q2 2026 EPS of $2.91 versus $2.42 expected. Technical indicators are bullish overall, with moving averages supporting upward trends. Revenue reached $222.58 billion in 2025, with net income margin improving to 0.67%.

Outlook remains positive driven by robust pharmaceutical demand and optimistic FY2027 guidance. Key risks include high debt levels and thin profit margins. Analysts maintain a bullish consensus with a $266.43 price target, representing 12.5% upside. The stock presents a growth opportunity but requires monitoring of margin pressures and cash flow volatility.

GLBE trades at $39.76, down 3.38% on the day, with a bullish technical signal from moving averages and strong analyst support. The company reported Q2 2026 earnings that beat expectations, with revenue up 39% year-over-year and an adjusted EBITDA margin expansion to 20.9%. Recent news highlights the acquisition of Passport to enhance logistics capabilities and a $500 million share repurchase program authorization.

The outlook is positive, with 100% buy ratings from analysts and a consensus price target of $44.75 implying 12.5% upside. Key opportunities include robust revenue growth and margin expansion, while risks involve high valuation multiples and insider selling activity. The stock's trajectory hinges on continued execution of its global e-commerce enablement strategy.